Authors


Brian Miller, MD, PhD, MPH

Latest:

The Effects of Psychedelics in Healthy Participants

In a well-blinded study, researchers investigated and directly compared the acute effects of LSD and psilocybin in healthy participants.


Russ Conroy

Latest:

FDA Grants Priority Review to Liso-Cel in Relapsed/Refractory CLL/SLL

The FDA acceptance marks the first step in addressing the unmet need for a lasting treatment option for patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.


Madeline Colli

Latest:

Healthcare Provider-Focused Medical Cannabis Research Study Launched by Cannabis Center of Excellence, Medicinal Genomics, and UMass Dartmouth

The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.


Steve Riddle, PharmD, MSIM, FASHP, BCPS

Latest:

The Pharmacist’s Role Beyond COVID-19

Amid the pandemic, how effectively pharmacists embraced their role as frontline care providers could change the profession forever.


Samantha Troy, 2021 PharmD candidate

Latest:

Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma

Melphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.


Ginny Langbehn

Latest:

Thriving in a Digital World: Marketing Strategies for Independent Pharmacies

Cut through the online noise with these digital marketing tips for your independent pharmacy.


Denise Kelley, PharmD, BCPS, FASHP

Latest:

Q&A: Pharmacists’ Understanding of CKD Therapies, Adverse Effects | ASHP Midyear

Denise Kelley, PharmD, BCPS, FASHP, joined Drug Topics to discuss various medications for chronic kidney disease and their common adverse reactions.


Todd Bertoch, MD

Latest:

New Data Shows Cebranopadol’s Potential in Acute Pain Management

A conversation with Todd Bertoch, MD, chief medical officer for pain research at CenExel and an investigator on the ALLEVIATE-2 trial.


Kevin Klembczyk, MD

Latest:

Cannabinoid Hyperemesis Syndrome: Diagnosis and Management

A deep dive for pharmacists into this frequently debilitating disorder


Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST

Latest:

The Unique Challenges, Growth in the Business of Health-System Pharmacy

From market pressures to regulatory framework, Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed growth in the business of health-system pharmacy and the challenges it has faced.


Christine Payne

Latest:

Best Practices on Discussing Birth Control for Adolescents

There are numerous methods of contraception available for adolescents.


Jennifer Bacci, PharmD, MPH

Latest:

Q&A: Building a Better Future for Community Pharmacy

Jennifer Bacci, PharmD, MPH, discusses ways to improve current issues impacting community pharmacy.


Colin Turnbull, PharmD candidate

Latest:

The Evolution of Pharmacogenomics

Pharmacogenomics provides an opportunity for pharmacists to enhance their role in patient care.


Jonna Lorenz

Latest:

Symptom Scoring Framework Helps Formalize Definition of Long COVID

Finalizing a definition for postacute sequelae of SARS-CoV-2 infection will lead to high-quality care and treatment for patients suffering from the condition.


Jeffrey Fitzgerald, JD

Latest:

National Pharmacy Chain Opioid Settlements Poised to Affect Independent Pharmacies

Stipulations of the settlements include data reporting, annual training, and an independent compliance officer.


Rich Parker, MD

Latest:

Understanding What Vaccines Could Mean for Long COVID

Research suggests that COVID-19 vaccination may serve a therapeutic effect, possibly reducing the risk of developing long COVID when administered to those currently infected.


Joseph P. Nathan, PharmD, MS

Latest:

Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea

Evidence of the relationship between probiotics and antibiotics is lacking.


Julia Vu, PharmD

Latest:

Empowering Pharmacists with Responsible AI

A Patient Care Journey from a Pharmacist Perspective


Morgan Petronelli

Latest:

FDA, CDC Increase Availability of RSV Monoclonal Antibody for Infants

The federal agencies said that they will continue to work closely with manufacturers to maintain the availability of the vaccines through the end of 2023 and early 2024 to meet the demand during the RSV season.


Emily Leppien, PharmD, BCPS, BCPP

Latest:

Recap: Pharmacists Share The Biggest Takeaways from APhA 2025

Experts discuss what they learned at the American Pharmacists Association Annual Meeting and Exposition 2025.


Jennifer Zilka

Latest:

What is Being Done to Address Pharmacy Deserts in the US?

Cencora representatives with expertise into pharmacy desert insights joined Drug Topics to discuss issues in pharmacy access and what is being done to address them.


Killian Meara

Latest:

Pharmacist Involvement Helps Reduce Time to A1c Target

Patients who received pharmacist support reached their A1c goal 14 months sooner than those who did not receive the care.


Sebastian Krawiec

Latest:

FDA: CBD Requires Separate Regulatory Pathway from Dietary Supplements, Food

The agency intends to work with Congress to create a pathway that balances the desire for access with regulatory oversight and risk management.


April Gill

Latest:

How Pharmacies Can Help Move Health Equity Forward

As costs increase and the number of people in need further outpaces resources, it becomes increasingly urgent to find ways to further extend services to the people who need them.


Rina Lokaj

Latest:

Early CT Screening Linked to Improved Lung Cancer Survival

Although early computed tomography (CT) screening was associated with improved cure rate for patients with lung cancer, less than 6% of the population that is eligible receives it.


Jessica Li, PharmD candidate

Latest:

FDA Approves Oral Treatment for Postpartum Depression

Last August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.


Donna Hallas

Latest:

Pediatric Vaccines Strongly Recommended, Study Shows

Not every vaccine is required, some are just strongly recommended. Here's what to know about 5 recommended vaccines.


Emma Andrus

Latest:

Breaking: Benzene Found in Acne Products From Major Brands, Prompts FDA Recall Petition

Following investigation by the independent testing laboratory, Valisure found acne products that contain up to 12 times the allowed of benzene.


Kurt Proctor, PhD, RPh

Latest:

NCPA's New Consortium Exemplifies Preparedness in Community Pharmacy

The new initiative is a way for NCPA to proactively engage its network of community pharmacies during a potential public health crisis.


Tony P. George, MD, FRCPC

Latest:

College Students and Misuse of Substances

The prevalence of annual alcohol consumption is highest in full-time college students 1 to 4 years after high school.

© 2025 MJH Life Sciences

All rights reserved.